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Abstract
Perceived Control o f Chronic Obstructive Pulmonary Disease and Adherence to a
Therapeutic Regimen
By
Lori A. Booms

The purpose o f this research study was to examine if a difference existed between the
concept o f perceived control o f the effects and course o f the COPD and the adherence to
the prescribed therapeutic regimen. The conceptual framework for the study was the
Multidimensional Health Locus o f Control. The study design was a comparative
descriptive survey. Data collection was completed by using the three instruments:
Multidimensional Health Locus o f Control (Form C), Health Value Measurement, and
Measurement o f Compliance with a Comprehensive COPD Treatment Program. The study
consisted o f 20 participants. The findings o f the study showed no significant difference
existed in the levels o f health values between COPD patients with internal and external
locus o f control and in the levels o f adherence. No variability existed in levels o f adherence
between COPD patients with varied health values and internal and external locus of
control. Implications for nursing research and further research are presented.
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Chapter 1
iDtroductioD

Introduction
Chronic Obstructive Pulmonaiy Disease (COPD) is a major cause o f disability, second
only to coronary artery disease (Goroll, May, & Mulley, 1995). According to Goroll,
May & Mulley, it is predicted that 3% of Americans will develop COPD. COPD is a
disease that is incurable, with minimal reversal o f effects. The prime treatment goals are
limiting complications and maximizing functional ability. In many cases, complex and
multiple treatment regimes are required to assist the person in maintaining adequate
functioning levels. Ferguson and Chemiack (1993) estimate that at least 15 million
Americans are affected with COPD. McCance and Huether (1994) noted more than onethird o f all patients admitted to Veteran's Administration facilities have evidence o f COPD.
In addition, the death rate has risen by 22 percent in the last decade, with the mortality
rate at greater than 50 percent at 10 years after diagnosis.
COPD is primarily caused by long term tobacco use, but exposure to noxious dusts and
gases may contribute to the development o f COPD. Obstructive diseases are commonly
noted as adult asthma, chronic bronchitis, emphysema. Obstructive diseases cause
insidious pathologic changes in the lung tissue, which leads to a chronic condition.
Obstructive diseases are characterized by airway obstruction, air trapping, dyspnea, and
frequent infections. Physiological changes manifest as abnormal ventilation-perfusion
ratios, hypoxemia, hypoventilation, and a late manifestation of right-sided heart failure.
The physiological changes then lead to psychosocial changes due to decrease activity
tolerance as a result o f chronic hypoxemia. The psychosocial manifestations most
experienced by COPD patients are isolation, loneliness, depression, fhistration, anger, and

anxiety. Management o f people experiencing COPD should be designed to educate
patients and families, slow the progression o f airflow limitations, and correct secondary
physiological manifestations (Phipps, Long, & Cassmeyer, 1994).
Regardless o f which chronic illness a person may experience, lifestyle is forever
altered. Patients with COPD must endure complex medical treatments o f medication,
respiratory therapy, exercise and modified diets. Complex regimes may not be consistent
with the person's perception o f an acceptable lifestyle. Cameron and Gregor (1987)
noted " a patient with chronic disease assesses recommended treatments on how well they
can be integrated into his life....an individual's perception's o f his situation will determine
whether or not he will comply with a medical regime"(p.671).

Cameron and Gregor

report that there is a consistently high rate o f non-compliance among COPD patients.
There are many factors which contribute to non-compliance among people with chronic
illness. One o f the most significant factors that may affect compliance is a person's
perceived ability to control the effects and course o f the disease. Given and Given defined
compliance as a "human response to promote, maintain, or restore health" (1989, p.97).
Perceived ability to control health or disease has been examined in many theories. The
definition o f perceived control has its roots in the social learning theory o f Rotter's (1966)
Generalized Expectancies for Internal versus External Control of Reinforcement,
commonly referred to as Locus o f Control. A relationship has been shown to exist
between perceived ability o f personal control of health behaviors and compliance as
supported in studies by Williams(1972) on seat belt use and Brown, Muhlenkamp, Fox,
and Osborn (1983) on the relationship between locus o f control, health values, and
positive health practices. As described in a study by Wallston, Wallston, Kaplan and
Maides (1976), by structuring a weight loss program on each persons' locus of control
(internal or external), an increased weight loss will result. "Perceived control of health
appears to influence the efifectiveness of diflfering strategies for inducing or facilitating
continued practice o f health-promoting behaviors" (Pender, 1987,61). Pender discussed

having a strong desire for control o f health should result in health promoting behaviors.
Conversely, having a strong desire for control but having little perceived probability of
control may result in frustration, helplessness, and behavioral inhibition.
Health enhancement and maintenance is the desirable outcome o f the nurse-patient
relationship. As the nurse provides interventions to enhance and maintain the patient's
health, there must be an awareness o f the patient's locus o f control and perceived ability to
control the COPD. The cost o f measuring lack of adherence to a therapeutic regimen is
difficult to fully assess. The costs can be sometimes seen in hospital admissions, primary
care providers visits, and emergency department interventions. The cost of lack of
adherence is not limited to health care dollars but also the cost to families and society in
general due to lost o f productivity and role fulfillment. Therefore, exploring the patient's
perception o f the ability to control his or her COPD when designing a therapeutic regimen,
will enhance health maintenance and maximize physical and social functioning.
The purpose o f this research study was to examine if a difference existed between
the concept o f perceived control o f the effects and course of the COPD and the
adherence to the prescribed therapeutic regimen.

Chapter 2
Conceptual Framework and Literature Review

Conceptual framework
The theory o f Health Locus o f Control will serve as a framework for this research
study. Rotter (1966) first described the personality dimension o f locus o f control. Within
Rotter’s Social Learning Theory, a person's actions are predicted based on his values, his
expectations, and the situation in which he finds himself. Lefcourt (1976) described this
theory as the potential occurrence of a set o f behaviors that lead to the satisfaction o f a
need (need potential) which is a function o f both expectancies that these behaviors will
lead to reinforcements (freedom of movement) and the strength or values o f these
reinforcements (need value). Lefcourt (1976) noted Rotter’s theory defined reinforcements
(freedom o f movement) as the generalized expectancy o f success resulting from one’s
ability to remember and reflect upon a lifetime o f specific expectancy behavior-outcome
sequences.
From Rotter’s Theory the concept of perceived control has been defined as a
generalized expectancy for internal as opposed to control of reinforcements.(Lefcourt,
1976). The concept o f the internal locus o f control can therefore be conceptually defined
as perceived control. Jensen, Turner, Romano, & Karoly (1991) identified three aspects of
perceived control: (1) beliefs about controllability, (2) beliefs about ability to cope, and (3)
expectations about outcomes.
Individuals with external locus o f control believe their outcomes are governed by
external forces such as fate, chance, or other people. Individuals with internal locus o f
control believe their outcomes are determined by their own actions and abilities. Rotter’s
Theory (1966) stated that the generalized expectancy o f internal control (internal locus of
control), refers to perception o f events, as being a consequence of one's own action and
being under personal control. Conversely, the generalized expectancy of external control

(external locus o f control) refers to the perception o f events being unrelated to one's own
behavior and being out o f one's own control. Weitin (1992) identified that locus of
control is not an either-or proposition. Locus o f control being a personality trait occurs
on a continuum.
Wells (1994) argued that an internal belief in control increases perseverance towards a
goal if success is attributed to one's skill or ability.

Individuals with an internal locus of

control were hypothesized by Jensen et al.(1991) to adjust better to chronic symptoms
than those with an external locus o f control. Beck, Rawlins, and Williams (1988) related
that those with an internal locus o f control perceive that they have control over events that
affect them. Wells (1994) noted that the greater control one perceives, including the
ability to alter the outcome, as well as cope effectively, the better the adjustment to
chronic symptoms.
Definitions
1). Locus o f Control is the belief an individual has about health/illness events in life
which may or may not be controlled by the individual.
(a) internal locus o f control (perceived control)- the perception that health
or illness can be controlled by the individuals skills and abilities.
(b) external locus o f control-the perception that health or illness
cannot be controlled by the individual and is contingent on
outside forces such as powerful other (Physician or Creator), fate,
chance, or luck
The term multidimensional health locus of control is used to encompass all the
components: intemality, chance, powerful others, doctors, and other people, o f locus of
control (Wallston, Stein & Smith, 1994).
2).Compliance is the outcome or reinforcements o f behaviors and activities which
promote, maintain or restore health functioning. Rotter (1975) in reviewing research
studies already completed noted the lack of measuring the value of the reinforcer.
5

The value o f the reinforcer is defined as the outcome o f compliance, which is health.
3). Health has been defined by many authors, but the most appropriate definition would
be the one that the patient believes is most appropriate. Therefore, health is the
perception o f physical, mental and social well being as defined by the person experiencing
that phenomenon despite the presence or absence o f disease.
Review o f Literature
The review o f the literature will examine two areas, studies examining Locus o f
Control and Compliance among COPD and other chronic illnesses, and literature
examining the issues related to compliance.
Literature on Locus o f Control
Johnson's (1989) Disease-Related Knowledge, Multidimensional Health Locus of
Control, and Compliance with Treatment o f the Patient with COPD study investigated 30
patients at University o f Tennessee Medical Center, Knoxville. Each subject had a medical
diagnosis o f chronic obstructive pulmonary disease and was hospitalized at time o f the
study. The design o f the study was nonexperimental.
Johnson (1989) addressed three questions. The questions were: 1) What was the
significant relationship between the COPD related knowledge and the multidimensional
health locus o f control (MHLC) scale? 2) What was the association between the COPD
related knowledge and the level o f treatment compliance? 3) What was the significant
relationship between the MHLC and the level of treatment compliance?. Measurements
were made by using the MHLC Scale Form A (Wallston ,1978), Disease Related
Knowledge Test (Johnson, 1989), and Compliance with Treatment Form (Johnson, 1989),
both specifically constructed for this study.
Johnson's (1989) findings indicated that no significant relationship existed between the
MHLC dimension and COPD related knowledge. In addition, no significant relationship
existed between external or internal MHLC dimension and compliance with treatment.

Johnson (1989) did find that the amount of knowledge held by patients had a significant
positive affect on the level o f treatment compliance.
Limitations noted by Johnson (1989) included the use of a convenience sample of
patients, and the potential that the incidental sampling technique might have influenced the
study. Johnson (1989) suggested the study should be replicated in a different geographic
setting with further investigation into reasons for failure to comply with treatment
regimens.
Wightman (1993) examined health value and health locus o f control impact upon
compliance in cardiac patients. Wightman's study consisted of 40 post myocardial
infarction and post cardiac surgery cardiac rehabilitation clients. The study design was ex
post facto. The study used the MHLC scale, the health value survey, and the health
behavior scale.
The hypothesis stated that persons with internal locus of control and high value of
health had increased compliance. No statistical significance was found to support the
hypothesis. Limitations noted included small sample size, a homogeneous population
which limited application to the general population, using only one collection site limiting
cultural and demographic diversity, and not enough variability in MHLC scale and health
value data to explain the research. Recommendations for further study included by
increasing numbers o f clients with a internal locus of control and high health value and
those with external locus o f control and a low health value that a significant relationship
may have been produced.
One study that appeared to support the concept o f incorporating MHLC in treatment
regimen development was conducted by Kerr (1986) looking at adherence and lowered
diastolic blood pressure. The sample consisted o f 115 volunteer persons with hypertension
who were employed at a large newspaper publishing firm and two telephone companies.
The study design was descriptive correlational. Dependent variables were adherence to
prescribed medication as measured by percentage of actual medications and diastolic

blood pressure readings taken at the beginning and end o f the study. The three
independent variables were MHLC scale scores, profiles o f health locus o f control
characteristics, and health value scale.
Kerr's (1986) basic assumption that health locus of control beliefs contribute to the
prediction o f health behaviors was supported. No limitations were noted. Although,
recommendations for further study in MHLC profile characteristics of hypertensives as
predictors o f lowered diastolic blood pressure were suggested.
Schneider (1992) administered the MHLC Scale to 137 chronic hemodialysis
outpatients to examine the relationship between the scores and serum phosphorus as an
indicator o f dietary compliance. Schneider found that older clients tended to have higher
scores on powerful others scale and tended to be more compliant with phosphorus
restrictions than younger clients. Schneider postulated the possibility that expectancies of
patients may vary with diagnosis and experience with a given disease.
Therefore, age, disease severity and chronicity, and other psychosocial factors such as
marital support, or socioeconomic status can have a great influence on compliance, as well
as perception o f internal versus external locus of control.
Wells (1994) examined Perceived Control over Pain: Relation to Distress and
Disability. Wells' findings supported the relationship of control beliefs to distress and
disability in patients with chronic pain. Wells stated that knowledge o f the specific control
beliefs that a patient holds can guide the types of interventions that are used. Thus
supporting the concept, that individualizing a therapeutic regime using a client's locus of
control can enhance adherence.
Literature on Compliance
Cameron and Gregor (1987) described the impact of chronic illness on compliance.
They noted a consistently high incidence of non-compliance among chronic disease
patients which suggested there is something about chronic disease which may contribute
to non-compliance. It was also noted that the time and energy required to complete
8

complex treatment regimen may not be worthwhile. As the complexity o f the treatment
increased, compliance decreased. Clients with chronic illness know that no matter how
eflScacious they are with treatment, they will not be cured. Cameron and Gregor related
that health professionals judge regimens on their medical worth, but clients judge regimen
on a social basis. The clients perception of the value o f the treatment on health is the basis
for adherence and nonadherence in many cases.
SchiafiSno and Revenson (1992) described the concept of perceived control, an issue
supported by several studies, as having a positive influence on adherence. SchiafiSno and
Revenson noted the belief in ability to control outcomes, an illusion of control, may be
more important than the reality o f the ability to control an outcome. The perceptions of
control were important for adaptation, this perception provides information about future
outcomes (SchiafiSno and Revenson, 1992). In addition, it was noted that those clients
with less controllable diseases experienced less perceived control and were less accepting
of the disease and those with a more controllable disease.
In summary, the relationship between MHLC and compliance has been not supported
in some studies and supported in others. The general recommendations produced a
recurrent theme, which suggested that further investigation needs to continue with the
incorporation o f other variables such as social support, education, self-efiBcacy,
cost/benefit, client/physician relationship and severity o f disease.
Absent from many o f the studies was the concept o f value of the reinforcer from
Rotter's (1966) theory o f locus o f control. Oberle (1991) noted that any future research
efforts should include the measures of the value o f the reinforcer. She also noted that,
further research should be consist o f quasi-experimental or experimental studies and more
attention needs to be paid to reliability and validity o f instruments.
The mixed outcomes maybe a result of some o f the limitations noted in the various
studies. The lack o f the value o f the reinforcer as a variable may also have had an impact
on the outcomes. Although the findings from multiple studies on locus of control have

been equivocal, there are studies that support the demonstration o f a relationship between
an internal locus o f control and adherence to health promoting behaviors, with resultant
decreased disability among various population types. This study utilized the
recommendation o f Oberle (1991) to include the concept o f the value o f the reinforcer. In
addition, this study was conducted on a different population, in a different setting, and in
the healthcare environment under going drastic changes.
Research has not always been able to support or refute the presence o f a relationship
between locus o f control and adherence. Because of that, this research study examined if
a difference exists between those with an internal and external locus of control and
adherence to a therapeutic relationship. Research on locus o f control and adherence to a
therapeutic regimen was important in determining if a significant difference existed
between the variables. If a significant difference existed, this will serve as an impetus to
develop specific interventions that will utilize this concept. Understanding the factors that
may affect adherence will serve to develop more efficient interventions, which will in turn
maximize functional ability and limit the complications experienced by those patients with
chronic obstructive pulmonary disease.
This study built on a study conducted by Johnson (1989) examining disease-related
knowledge, multidimensional health locus o f control (MHLC), and compliance with
treatment of the patient with chronic obstructive pulmonary disease. Replication of the
study was done to determine if the conclusions drawn by Johnson are applicable to other
populations with COPD and built on the limitations noted in that study. Another variable
added into this study was the concept of the value of the reinforcer (i.e., health) as noted
by Rotter (1975) and Oberle (1991). Many studies looking at locus of control have not
addressed this concept, thus creating criticism by Rotter and Oberle, who noted the need
to have this concept addressed in future research. Therefore, the purpose o f this study
was to expand on the generalizability from the various studies that supported the concept
o f having an internal locus o f control and maintaining adherence to a therapeutic regimen.
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The focus was; Does a diiBference exist between perceived control of chronic obstructive
pulmonary disease patients, and health value? What is the difference between perceived
control o f chronic obstructive pulmonary disease and adherence to a therapeutic regimen?
What is the difference between perceived control of chronic obstructive, health value, and
adherence to a therapeutic regimen? What specific demographic variables (i.e.,; age, sex,
length of illness, presence o f health insurance) describe perceived control o f chronic
obstructive disease (internal locus o f control or external); health value; and adherence to a
therapeutic regimen?
Operational Definitions o f Variables
Internal and External Locus o f Control
Internal and external locus o f control was measured using the Multidimensional Health
Locus o f Control (MHLC) tool (Wallston, Wallston & DeVillis, 1978). Internal locus of
control is reported as intemality because the majority o f responses are noted within that
specific subscale. External locus o f control is reported as chance and powerful others with
the majority o f responses noted in those particular subscales.
Health Values
Health Values was measured using the Health Value Scale (Lewis, Morisky, & Flynn,
1978). The overall rating obtained will provide measurement o f the importance o f health
to the patient.
Adherence
Adherence was measured using the Measurement o f Compliance with a Comprehensive
COPD Treatment Program (Johnson, 1989). This produced three potential outcomes of
measurement o f compliance: high, moderate, and low.

11

The hypotheses tested were:
1.) There is a difference in levels of health values between COPD patients with
internal and external locus o f control.
2.) There is a difference in levels of adherence between COPD patients with
internal and external locus o f control.
3.) Variability exists in levels o f adherence between COPD
patients with varied health values and internal and external locus o f control.

12

Chapter 3
Methodology

Research Design
The research design used for this study is comparative descriptive survey. Talbot
(1995) described comparative descriptive survey as a comparison between two or more
groups. It attempts to identify what difference exists between the groups.
The advantages o f the comparative descriptive survey study as noted by Talbot (1995)
is it can provide descriptive information about groups. It can determine if the groups are
the same o r different on specific variables which may lead to further research on a topic.
The disadvantage o f this type o f study is the relative weakness of design and inability to
determine the degree o f association between the variables.
Threats to internal validity to this type o f design are fairly limited. The potential threat
that may exist is instrumentation. The instruments utilized may not be as effective in
measuring what they claim. Another threat that may exist is in selection because the
sample to be utilized is a convenience sample. The people in this sample all have attended
a pulmonary education class which demonstrated their commitment to learning more about
their disease process which may indicate they have a internal locus o f control. This may
serve to explain if those people who seek out further education about their disease process
are internally controlled versus externally controlled individuals.
Another potential threat to external validity is the idea o f the "Hawthorne Effect".
Talbot (1995) described the Hawthorne Effect as subjects being aware they are being
studied which results in behavior modification. To avoid this from becoming a threat,
clients will be informed that all information is confidential so as not to fear any potential
repercussions fi"om their healthcare providers for any perceived lack of adherence to their
therapeutic regimen.
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Another potential threat to external validity is sample size and self-selection. The
sample size is limited due to the amount of participants in the class, as well as, the
participants choice to complete the questionnaires. One final potential threat is the
homogeneity that exists in the sample. Because this is a convenience sample this will be
hard to control. The difference in the sample selection for this study was the geographical
difference from Johnson's (1989) study, as well as a different time, and different setting.
Sample and.Setting This study was modified fi"om Johnson's (1989) by using a population that has already
attended a 5 week (2 classes/week) community pulmonary education program at a small
rural northern Michigan nonprofit hospital. The pulmonary education program is usually
conducted three times a year with approximately 10-12 participants per program.
Approximately seven sessions o f the program have been conducted since its inception. It is
a free program to the client and does not require a referral by a healthcare provider.
Johnson's (1989) population consisted of inpatients with COPD from The University of
Tennessee Medical Center, who had been provided with a teaching intervention during
their hospitalization.
Sample selection criteria are based on many factors and include: diagnosis o f chronic
obstructive pulmonary disease (emphysema, chronic bronchitis and asthma); the ability to
read and write in English; no concurrent terminal illness; and willingness to participate.
Any patients not meeting the criteria had questionnaires disregarded.
The sampling plan is a convenience sample. Talbot (1995) described the convenience
sample as using participants that are easily accessible to the researcher and meet the
criteria. The convenience sample advantages include, according to Talbot, ease o f
completion, and inexpensiveness. Talbot noted disadvantages to be sampling bias, the use
o f a sample that does not represent the population, and limited generalizability of results.
To prevent sample bias, all results were confidential to the researcher other than
demographics.
14

Sample size for this study was expected to be thirty respondents. Forty-eight
questionnaires were sent, with twenty questionnaires (42%) being completed and returned.
Talbot (1995) noted that studies that attempt to clarify concepts or examine relationships
need a larger sample. Johnson’s (1989) study consisted o f thirty subjects.
Instniments
To determine if a difference existed between an internal and external locus o f control
and adherence to a therapeutic regimen, three instruments were utilized.
The three variables are locus o f control (internal versus exterad), degree of adherence to a
therapeutic regimen, and value o f health (value o f the reinforcer). The instruments used to
measure the three variables are Multidimensional Health Locus o f Control Scales Form C
(Wallston, Stein, & Smith, 1994) (See Appendix A), Measurement o f Compliance with a
Comprehensive COPD Treatment Program (Johnson, 1989) (See Appendix B), and
Health Value Scale (See Appendix C). In addition demographic data was collected to
describe specific variables (See Appendix D). Written permission was obtained from:
Wallston to use the MHLC Form C (See Appendix E), Johnson to use the Measurement
of Compliance with a Comprehensive COPD Treatment Program (See Appendix F) and
Morisky to use the Health Value Scale (See Appendix G).
Locus o f Control
To determine if a person is generally considered to be internally controlled or externally
controlled the Multidimensional Health Locus o f Control Scale, Form C, was used.
MHLC Form C was specifically designed to be used with people with chronic conditions.
This instrument was developed by Wallston, Stein and Smith (1994). The format is a
Likert-type questionnaire with l=strongly disagree to 6=strongly agree. Form C
(Wallston, personal correspondence. May, 1995) is similar to Form A/B, which has 18
items. Form C is designed to be condition specific. Form C has four subscales: Intemality;
Chance; Doctors: and Other (powerful) People. The range of possible scores for each
subscale is: internal, 6-36; chance, 6-36; powerful others, 6-36; doctors, 3-18; and other
15

people, 3-18. Items 1, 6, 8, 12, 13, and 17 identified an intemality orientation. Items 2, 4,
9, 11, 15, and 16 identified a chance orientation. Items 3 ,5 ,7 , 10, 14, and 18 identified a
powerful others orientation. Items 3, 5, and 14 identified a doctors orientation. Lastly,
items 7, 10, and 18 identified an other people orientation. A total score is obtained for
each domain and the domain with the most points is labeled as the dominant domain. This
instrument produced at least three possible outcomes; intemality orientation, chance
orientation and powerful others. This resulted in interval level o f measurement.
Form C reliability has been established using two methods, internal consistency and
test-retest reliability (Wallston et al., 1994). Internal consistency was found to be .85-.87
for intemality subscale, .79-.82 for chance subscale, .71 for doctors subscale, and .70-71
for other people subscale. The test-retest correlations for the subscales were .64-66 for
intemality, .39- 61 for chance, .58- 66 for doctors, and .40-.54 for other people. Wallston
et al. reported that one would not necessarily expect a very high test-retest reliability for
the Form C subscales, especially over extended periods of time because individuals are
exposed to experiences that alter their beliefs.
Construct validity for Form C was established by demonstrating increased mean
Intemality scores and decreased mean Extemality scores after an intervention for those
who experience chronic pain (Wallston et al., 1994). Concurrent validity was established
by demonstrating a high correlation with the appropriate counterparts on MHLC Form B.
In addition, a significant relationship existed between Levenson’s Intemal, Powerful
Others, and Chance and Form C appropriate counterparts Intemality, Chance and Other
People scales. Data were collected from 588 patients with four conditions-rheumatoid
arthritis, chronic pain, diabetes, and cancer. Data from arthritis and chronic pain
established that Form C subscales were moderately stable and possessed considerable
concurrent and construct validity ( Wallston et al., 1994).
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Adherence to a Therapeutic Regimen
Measurement o f adherence to a therapeutic regimen was done with the Measurement
o f Compliance with a Comprehensive COPD Treatment Program instrument developed
by Johnson (1989). This instrument is a survey type questionnaire. It was developed to
ascertain an individual's degree o f compliance with a treatment plan. The instrument
consists o f 23 questions. The maximum number of points possible is 100. Behaviors most
conducive to disease control are scored at 10 points for a correct answer. Other questions
reflecting compliance were scored at 5 points. Behaviors not conducive to disease control
were scored on a descending order (3 ,2 , 1, 0 ,-1 ) hi relation to the impact on the disease
process. Total points received were summed as a total score. The instrument produced
three outcomes: high compliance (scores 85% to 100%), moderate compliance (scores
70% to 84%), and low compliance ( scores 0 to 69%). These rankings resulted in interval
levels o f measurement.
No reliability or validity has been reported for this tool. Johnson (1989) did report
that a panel o f experts consisting o f an RN Administrator of Tri-County Respiratory
Clinic, a Nursing Professor with experience developing instruments, a Pulmonary
Physician, and an Associate Professor o f Education with experience in statistics, reviewed
the instrument and deemed it appropriate for use. The instrument was pilot tested during
June and July 1988. The instrument was administered to 16 COPD patients on 9 East
Respiratory Unit at the University o f Tennessee Medical Center during pilot testing.
Value o f Health
The Health Value Scale was used to measure the patient's perception of the value of
health (value o f the reinforcer). The health value scale measured how subjects valued
health in comparison to work, family and money (Lewis, Morisky, & Flynn, 1978).
The instrument consists of a three items. Kerr (1986) reported using the sum and the
average o f this scale. Kerr obtained average scores of 2, with a mean o f 1.806, standard
deviations o f .25, and alpha o f 0.44.
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The data obtained from the Health Value Measurement resulted in an interval level of
measurement. The measurement offered the respondent five possible choices to three
questions regarding which choice was most important to them. Each choice is coded with
health being (3), money, family, work (2), not sure (1), and no answer or N/A (0). The
total score is obtained and averaged. Morisky (personal communication, Oct. 22,1996)
reported having obtained the following frequencies for the times an individual values
health over money, family, or jobs: (0) 12%, (1) 17.4%, (2) 39%, (3) 31.5%.
Reliability (Cronbach's Alpha) o f all instruments was examined using data from this
study. Talbot (1995) noted that o f score o f 0.70 or higher is desirable. The reliability for
the MHLC (Form C) subscales were: Intemal = .334, Chance = .6713, and Powerful
Others = .4831. The reliabilities are lower than those reported by Wallston et al.(1994).
This may be due to small sample size, number of items and missing data.
The reliability for the Health Value Scale was .298. This reliability was lower than
that reported by Kerr ( 1986). This may be due to small sample size, number o f items and
missing data. Instrument developer, D. Morisky (1996) did not report reliabilities.
The reliability for the Compliance with a Comprehensive COPD Treatment Program
was .2099. There is no reported reliability for this instrument by developer Johnson
(1989). The low reliability may be due to small sample size, number o f items and missing
data.
Demographics
Demographic data was collected to include: age, gender, martial status, presence of
health insurance, race, education, rating of health status, length o f illness, type of
healthcare provider. This data described those patients within the dominant domains of
locus o f control (intemal, external, or chance); value of health; and adherence to a
therapeutic regimen. A form was developed to collect demographic data. Given and
Given (1989) noted that demographic data has not seemed to consistently influence
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adherence, but it may modify the patient response and influence the therapeutic
relationship.
Procedure
Subjects were recruited from the Pulmonary Education Program using current and
past class rosters. Written permission to use the class rosters was obtained from C.
Schepers, RRT, current program director of the Pulmonary Education Program o f Mercy
Health Services North. (See Appendix H) .This study was submitted to Grand Valley
State University's Human Research Review Committee for approval with approval granted
(See Appendix I).
All eligible subjects were sent questionnaires to complete with an attached cover letter
(See Appendix J) that explained the purpose and a description o f the minimal risks
associated with completion o f the questionnaire. The cover letter included mention that
they were contacted because o f participation in the Pulmonary Education Program. A
disclaimer about confidentiality and lack o f adverse impact on the quality of care received
by participating in the study was included in the cover letter. A statement was included to
say that completing the questionnaires indicate informed consent. In addition, the letter
included that a request for a copy o f the study's results will be sent to the participants.
Postcards were sent approximately 2-3 weeks after initial letter to initiate follow-up.
Subjects were contacted by mail only. Receipt o f the cover letter constituted informed
consent even though there is no intervention or manipulation done. Return of the
questionnaire constituted informed consent to participate.
Questionnaires consisting o f : Form C MHLC Scale, Measurement of Compliance with
a Comprehensive COPD Treatment Program, and the Health Value Scale, were be mailed
to all participants with prestamped return envelope. Each questionnaire included an
instructional note informing participants to answer each question to the best of their ability
with no answer being wrong or right. Questionnaires were prepared with larger type to
ensure ease of reading for the participants. Completion of all instruments took
19

approximately one-half hour. Upon receipt o f completed questionnaires, data collection
and analysis began.
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Chapter 4
Data Analysis Results
The purpose o f this research study was to examine if a difference existed between the
concept o f perceived control o f the effects and course o f the COPD and the adherence to
the prescribed therapeutic regimen. Data was collected by questionnaire format. Data
analysis was done using the Statistical Package for the Social Sciences (SPSS).
Descriptive statistics are presented to describe sample characteristics, intemal and
external locus o f control, levels o f health values, and levels of compliance. The sample
consisted o f 20 participants (n=20) with one participant having missing data therefore all
statistics are for 19. The mean age o f participants was 66.6 years (S.D.=7.0) with a range
o f 55-78 years. The participants reported living with COPD for a mean of 10.1 years
(S.D.= 8) with a range o f 1-35 years. The mean educational level was 12 years (S.D.=2)
with a range o f 8-18 years. The characteristics o f patients with COPD who participated in
this study are presented in Table 1.
Table 1
Characteristics o f Patients with COPD (n=\9)

characteristic

percentage (%)

frequency (n)

gender:
male

8

42

11

58

17

90

divorced

1

5

widowed

1

5

female
martial status:
married
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Table ï cont.

Characteristics o f Patients with COPD (cont).

characteristic______________ frequency Tn)________percentage (%
Concurrent Illness:
yes

11

55

no

8

40

8

42

11

58

Insurance Coverage:
one source only
two sources

Healthcare Provider for Lung Disease:
pulmonary specialist

15

75

intemal medicine

4

20

general practice

4

20

two providers

4

20

Multidimensional Health Locus o f Control
The instrument Multidimensional Health Locus o f Control (Form C) (Wallston et
al., 1995) produced three categories (intemal, extemal, combined) in which the
participants were identified based on obtaining the highest total scores in a specific
subscale. The subscale, extemality, was determined by combining the subscales of
chance, powerful others, and doctor. Those participants that scored equally on the
intemal subscale and extemal subscale were identified as combination. The total scores
and determination o f locus o f control results are presented in Table 2.
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Table 2

MHLC Total Scores and Determination o f Locus o f Control (n=20)

score range

frequencyln)

percentage(%)

intemal

16-34

4

20

extemal

3-31

10

55

combination

n/a

3

15

missing data

n/a

3

15

Health Value Scale
The Health Value Scale provided a measurement o f the participant's value o f health by
ranking health in comparison to other variables on a 0 to 3 scale (O=lowest, 3=highest).
Participants scored a mean o f 2.77 (SD= .36) on the Health Value Scale.
The Health Value Scale rankings from the individuals that were identified as intemal,
extemal, and combination locus o f control are presented in table 3.
Table 3
Health Value Rankings o f Intemal, Extemal, and Combination Locus o f Control

Locus o f Control

Score Range________ mean________ S.D.

Intemal (n=4)

2.33-3.0

2.66

.272

Extemal (n=10)

1.66-3.0

2.8

.45

Combination (n=3)

2.66-3.0

2.77

.192

Measurement o f Compliance with a Comprehensive COPD IreatmenLProgram
The Measurement o f Compliance with a Comprehensive COPD Treatment Program is
a measurement of the participant's compliance by ranking health behaviors. A participant
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can score 100 possible points. Participants are then identified as high compliance,
moderate compliance, and low compliance based on the total score obtained. Levels of
compliance among internal, extemal and combination locus o f control individuals are
presented in Table 4.
Table 4
Level o f Compliance and Internal. Extemal and Combination MHLC

MHLC

Score Range Mean (S.D.)

Level of Compliance
High
85-100

Low

Moderate
70-84

0-69

Intemal (n=4)

49-73

59.2(10.9)

0

1

3

Extemal (n=10)

53-77

67.1(8.67)

0

5

3

61.66(18.6)

0

1

2

Combination (n=3) 42-79

Characteristics o f Intemal, Extemal and Combination Locus of Control Participants
Participants identified as intemally controlled individuals (n=3) were 50% (n=2) male,
25% (n=l) female, and with 25% (n=l) with missing data. Those participants identified as
extemally controlled individuals (n=10) were 30% (n=3) male and 70% (n=7) female.
Combination controlled individuals (n=3) were 33.3% (n=l) male and 66.7% (n=2)
female. Fifty percent (n=2) o f intemally controlled individuals reported a concurrent
illness, while 60% (n=6) o f extemally controlled individuals and 66.7% (n=2) of
combination controlled individuals reported a concurrent illness. Selected characteristics
of intemally, extemally and combination individuals are presented in Table 5.
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Table 5

Controlled Individuals

Locus o f Control

Mean Age fS.D.'l

Mean Yrs COPD TSXLl MeanEcLfSJDJ

Internal

62(8.8)

9.66(2.5)

12.33(2.88)

Extemal

67.4(6.2)

10.4(9.6)

12.3 (2.2)

Combination

66.6(9.0)

6.66(4.72)

12.3(5)

Key: Yrs-years Ed.-education
Hypothesis 1: There is a difiference in the levels of health values between COPD
patients with intemal and extemal locus o f control was not supported. The t-test results
obtained were: t= -55; d f 12; and p=.595.
Hypothesis 2; There is a difiference in the levels of adherence between COPD patients
with intemal and extemal locus o f control was not supported. The t-test results obtained
were: t= -1.36; df 10; p=.202.
Hypothesis 3 : Variability exists in levels o f adherence between COPD patients with
varied health values and intemal and extemal locus o f control was not supported.
Multiple regression produced; F=.54; p=.59.
To determine if a difiference existed between the two levels of control and certain
demographic variables analysis o f variance (ANOVA) was performed. The levels, intemal
locus o f control and extemal locus o f control and the variables, length o f education, years
of COPD, and age were used. No significance differences were found.
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Chapter 5
Discussion
Conceptual Framework
The framework o f Multidimensional Health Locus o f Control used for this study does
not appear to provide the explanation for why some people are more adherent to a
therapeutic regimen and than others. Rotter (1966) stated individuals with intemal locus
o f control perceived that the consequences of one's own actions(adherence) determined
events (health) and individuals with extemal locus o f control perceived events (health) as
being out o f their control. The concept o f patients with intemal locus of control and high
value of health (value o f the reinforcer) tended to be more compliant was not supported.
This study did not provide any support to the concept o f intemal health locus of control
versus extemal health locus o f control being a determinant o f adherence.
Anderson, DeVellis, Sharpe and Marcoux (1994) raised concem over measuring the
desire (hope) for control versus the expectancy (belief) for control when we employ the
Multidimensional Health Locus o f Control Scales. Anderson et al. concluded that
reexamining the construct validity o f the measures may give a better measurement of
health locus o f control by determining the desire versus the expectancy for control. This
revision o f the widely used MHLC Scale may provide better support of the intemal versus
extemal locus o f control and adherence concept.
Previous Research Findings
The lack o f support for the hypotheses is consistent with Johnson's (1989) DiseaseRelated Knowledge, Multidimensional Health Locus o f Control, and Compliance with
Treatment o f the Patient with COPD and Wightman's (1993) Health Value and Health
Locus of Control Impact upon Compliance in Cardiac Patients. Johnson (1989) found
that no significant relationship existed between intemal and extemal MHLC and
compliance with treatment. Wightman (1993) also found no significant difference existed
with health value, and health locus o f control impact upon compliance in cardiac patients.
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This study produced three participants that scored equally in both domains, intemal
and extemal. A reference to individuals that scored equally in both intemal and extemal
locus o f control was not found in the literature. No reference was made by Wallston
(1995) on how to score or label these individuals. As noted by Weitin (1992), locus of
control is not an either-or proposition. The finding o f combination individuals is
consistent with Weitin's concept. No statistically significant variance of demographic
factors seemed to explain individuals with a combination locus o f control as determined by
using ANOVA. Although, the combined individuals had a mean years (6.66) of COPD
less than those with intemal (9.66 years) and extemal (10.4 years) locus of control.
Schneider (1992) noted that older clients tended to be more extemally controlled. A ttest between locus of control and age produced no statistical significant. This study did
note that intemally controlled individuals were a mean o f 62 years (SD=8.8) and
extemally controlled individuals were a mean o f 67.4 years (SD=6.2). This is consistent
with Schneider's findings.
Cameron and Gregor (1987) noted a consistently high rate o f non-compliance among
COPD patients. The results o f this study are consistent with those findings. This study
found 44% (n=8) scored in the low compliance range, 55% (n=10) scored in the
moderate compliance range and 0% (n=0) scored in the high compliance range.
Limitations
Limitations o f this study were a small sample size, sampling technique, low alpha
instmment scores and missing data. The small sample size, a homogenous population and
replication o f the Pulmonary Education Program limited the study's generalizability.
Possibly with a larger sample size and a different sampling technique, differences may have
been found. The instruments had low reliabilities which could have an impact on the
statistics obtained, therefore creating another limitation by greatly affecting the power of
the statistics obtained.
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Application to Clinical Practice
The application o f these findings to clinical practice is that health locus of control is
not a conclusive predictor o f health behavior, but can lend insight into decision for the
most eflRcacious nursing intervention with varied levels o f locus o f control
(Schillinger,I983). Multiple factors (social support, self-efficacy, severity of disease,
health beliefs, etc.) influence compliance and those factors need to be assessed to design
efficient nursing interventions. In addition, the nurse must remember that health locus o f
control changes over time and is affected by current personal and social stressors.
As shown by responses that participants included with their surveys, there are several
factors which influence compliance. One participant noted, "I and my husband were both
unaware o f how harmful smoking was until it was to late and the damage was done." This
is consistent with the concept o f perceived threat to one's health in the Health Belief
Model (Kison, 1992). Assessing the perceived threat and benefit to one's health is an
intervention the nurse can perform when assisting the patient with healthy lifestyle
modifications.
One participant stated," No matter what you do, never quit trying to stop smoking."
Many lifestyle modification inherent with adherence are very difficult and not without
fi’equent relapses. Nurses need to realize the enormity o f certain lifestyle modifications
and realize relapses are normal. The nurse also needs to reassure the patient that relapses
are normal and not a sign o f weakness. Continuous encouragement of smoking cessation
is a must but acceptance o f failure is necessary so as not to alienate the patient and
damage the nurse-patient alliance.
An important factor which surfaced many times was related to exercise. Many noted,
living in a cold weather climate severely limited their ability to walk for exercise. Some
stated they only walked in the summer months while others stated they only walked while
in Florida. This brings about the need to address indoor walking programs in the winter
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months. Nurses need to encourage schools, mails, etc. to allow for indoor walking
programs not only for patients with COPD but for everyone with exercise needs.
Participants were eager to be included in the survey as demonstrated by several
responses being sent from winter residences in Florida and Arizona. They were eager for
more information about the disease process. One participant asked about lung reduction
surgery as a treatment for COPD and another wondered about the results o f this study.
Most freely jotted ideas and comments in the margins signifying that patients truly want to
express their ideas and to have well informed input into their care.
Although the findings are not statistically significant, they are clinically significant.
Since COPD is usually associated with an older population group, as demonstrated by the
mean age o f 66.6 years, the considerations associated with age (i.e., mobility, income,
social support) must be included in developing treatment plans. In addition, an older
population is prone to concurrent illness, as demonstrated by 55% o f the participants
reporting a concurrent illness. Presence o f a concurrent illness complicates an already
complex treatment plan that requires multiple lifestyle modifications. The treatment plan
must consider the energy expenditures required to execute it. The COPD patients use
most o f their energy purely in the act o f respiration. Therefore, treatment plans must be a
low energy expenditure with the appropriate support services (i.e., chore services,
hygienic assistance) in place to assist the patient in successful plan adherence.
Initially at the inception o f the Pulmonary Education Program classes, most members
o f the multidisciplinary team development conunittee felt that participants who would
attend would be highly motivated and wanted personal control o f the disease process. This
proved unfounded with 55% o f questionnaire respondents being identified as extemally
controlled. Most members attended with spouses/ significant others, adult children, or
fnends. Some class participants were spouses of patients with COPD that desired further
information about the disease process and how to care for the spouse with COPD. Many
stated, "He won't come but I want to know what he can eat, what he can do, and how can
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I help him". For individuals identified as extemally controlled by powerful others, this is
an opportunity for family involvement in assisting with adherence to a therapeutic
regimen. As the classes were completed participants voiced, " We'll miss you" and "It's
like leaving family". A sense o f camaraderie existed which demonstrated the need for
ongoing social support.
Suggestions for Further Research
The recommendations o f other studies are supported in this study which recognize
multiple factors influence compliance in addition to health value and health locus of
control. Suggestions for further study include expanding the sample size by surveying
upcoming Pulmonary Education Program participants and extending the data base and
compare findings o f original study. In addition, adding a disease severity rating may also
provide insight into locus o f control. This severity rating could compare the patient's
perception o f disease status and the medical provider’s perception o f health status based
on pulmonary function studies, for example. This may explain the current locus of control
perception which can be affected by an exacerbation of the COPD. To assess the efficacy
o f the intervention, the pulmonary education class, administering a Pretest/Posttest to the
group participants may also produce a significant difference by helping to clarify their
perception of COPD and its treatment. Many participants and their spouses offered
various comments ranging from "I guess I am not as bad as I thought" to "I never realized
how sick my wife really was".
In addition, using different instruments with improved reliabilities may increase the
power of the statistics, allowing for subtle difference to be detected. As noted by
Anderson et al.(I994), reexamining the construct validity o f MHLC scales for desire
versus expectancy may also improve the findings of further research studies. This would
provide for a more defined measurement of MHLC.
Further investigation into the factors and reasons why some participants produced a
combination locus o f control may help determine the reason for adherence versus
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nonadherence. Controlling for social stressors may also give insight to changing locus of
control. A test-retest o f MHLC may provide for a more global measurement of locus of
control because it would evaluate if the locus o f control was fixed or affected by some
other concurrent variable.
In conclusion, although the hypotheses o f this study were not supported, the findings
were consistent with Johnson's (1989) and Wightman's (1993) findings. Further study
needs to occur with additional concepts to examine the interrelationship of multiple
variables and their effect on compliance. Ultimately, the researcher needs to keep in mind
the concept of the patient/family-healthcare provider, mutually agreeable treatment
approach to ensure optimal functional health status with limited complications for the
patient with COPD, or any chronic debilitating disease process.
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Appendix A

Appendix A

Multidimensional Health Locus o f Control Scale Form C
Please circle only one answer per question. Beside each question you will find a scale that
ranges fi'om (1) strongly disagree with the statement to (6) strongly agree with the
statement. Pick the answer that best describes your feelings.
l=stongly disagree
4=slightly agree
2=moderately disagree
5=moderately agree
3=slightly disagree
6=strongly agree
SD
MD D
A
MA
SA
1
2
3
4
5
l.If my lung disease worsens, it is
my own behavior which
determines how soon I feel better
again.
2.As to my lung disease, what will
be will be.
3 .If I see my doctor regularly, I am
less likely to have problems with
my lung disease.

1

2

3

4

5

6

4.Most things that affect my lung
disease happens to me by chance.

1

2

3

4

5

6

5.Whenever my lung disease
worsens, I should immediately
consult a medically trained
professional.

1

2

3

4

5

6

6 . 1 am directly responsible for my
1
lung disease getting better or worse.

2

3

4

5

6

7. Other people play a big role in
whether my lung disease improves,
stays the same, or gets worse.

1

2

3

4

5

6

8. Whatever goes wrong with my
lung disease is my own fault.

1

2

3

4

5

6

2

3

4

5

6

9.Luck plays a big part in
determining how my lung disease
improves.
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Appendix B

Appendix B

Measurement o f Compliance with a Comprehensive COPD Treatment Program
1. Do you smoke cigarettes? a. yes b. no (If no, skip to question 5)
2. How much do you smoke per day? a. less than 1/2 pack b. 1/2 pack
c. 1/2 pack but less than 1 pack d. 1 pack
e. more than 1 pack
3. Have you cut down on the amount you smoke since your lung disease was
diagnosed?
a. yes
b. no
4. If yes, by how much per day have you cut down?
a. less than 1/2 pack b.1/2 pack to 1 pack c. over 1 pack
5. Do you use aerosol spray products?

a. yes

b. no

6.Do you take the prescription medications prescribed by your doctor?
a. yes
b. no
7. Do you ever miss or skip a dose o f your medication?
a. yes
b. no (If no skip to question 9)
8. If yes, about how often do you skip a dose?
a. more than once a day
b. once a day c. once a week
d. once a month
e. once every 2 months or longer
9. Are you ever more than 1 hour late taking your medication?
a. yes
b. no (If no. skip to question 111
10. If yes, about how often are you late?
a. every day
b. once a weekc. once a month
d. once every 2 months or longer
11. Do you ever take less o f the medication that you are supposed to take?
For example take 1 pill instead o f 2 pills.
a. yes
b. no
12.Do you ever take more o f the medication than you are supposed to take?
For example take 2 pills instead o f Ipill.
a. yes
b. no (If no to question 11 & 12, skip to question 14)
13. If yes to question 11 and/or 12, about how often?
a. every day
b. once a weekc. once a month
d. every 2 months or longer
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14. Do you visit with people who have colds or flu?
a. yes
b. no
15. Do you get a flu shot every year?
a. yes
b. no
16. How much fluid or liquid do you usually drink in a days time?
a. 1-3 8 ounce glasses
b. 4-7 8 ounce glasses
c. 8 or more 8 ounce glasses
17. How many meals do you usually eat in a days time?
a.l
b. 2
C.3
d.4
e.5-6
18.Approximately how much food do you eat at each meal?
a. average amount
b. small amount
c. large amount
19. Do you eat protein foods every day such as meat, nuts, peanut butter?
a. yes
b. no
20. Do you take rest breaks during the day?

a. yes

21. Do you pursed lip breathing?

a. yes

b.no

22. Do you walk for exercise?

a. yes

b.no

23. If yes, about how much do you walk every day?
a. just around the house only when necessary
b. around the house more than needed
c. walk at least 1/2 mile per day
d. walk 1/2 to 1 mile every day
e. walk more that 1 mile every day.
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b. no

Appendix C

Appendix C
Health Value Measurement
1. Which is more important to you?
a. health
b. money
c. not sure

d.no answer

e. not applicable

2.Which is more important to you?
a. health
b. family
c. not sure

d. no answer

e. not applicable

3. Which is more important to you?
a. working
b. health

c. not sure
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d. no answer

e. not applicable

Appendix D

Appendix D
Demographic Data
Please tell me a little information about yourself.
1. Are you: male or female
2. Your age is:________
3. How many years have you had lung disease?_______
4. Are you: single married separated divorced widowed
5. What type o f insurance do you have: Medicare Private Insurance (BC/BS etc.)
Medicaid VA
Champus
None
Other:______________
6. Which type o f Doctor treats your lung disease: Intemal Medicine General Practice
Pulmonary Specialist
Other:___________________
7. Your highest level o f education:_______________
8. Besides your lung disease, do you have any other health problems: yes or no
If yes, what type o f health problems do you have:______________________

9. Is there any other information that you think may be important to share:

Thank You!
Lori Booms RN BSN
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Appendix E

VANDERBILT UNIVERSITY SCHOOL OF NURSING
HEALTH CARE RESEARCH PROJECT________________________________________________________
Station 17
Vanderbilt University î>/fcdical Center
Nashville, Tennessee 37232-8300

Telephone (615) 322-2520
Fax (615) 343-7711

To:

Fellow Health Researcher

From:

Kenneth A. Wallston, Ph D.

Re:

The Multidimensional Health Locus o f Control (MHLC) Scales

Thank you for your recent inquiry about our MHLC scales. Enclosed you will find copies o f all
three forms o f the MHLC (Forms A, B, & C) along with scoring instructions for the forms.
Forms A & B are the "general" health locus o f control scales thaf have been in use since the midlate 1970's (and were first described in Wallston, Wallston, & DeVellis, 1978, Health Education
Monographs. 4 160-170.) Each o f these two "equivalent" forms contain three 6 item subscales:
intemality, powerful others extemalitj^ and chance externality. In the past 15+ years, forms A/B have been
used in nearly a thousand studies and have been cited in the literature hundreds o f times.
Form C is a relatively new version o f the scale that we first started to develop in 1987. Form C is
designed to be "condition-specific" and can be used in place o f Form A/B when studying people with an
existing health/medical condition. [The way you make this happen is to replace the word "condition" in
each item with whatever condition (e.g., arthritis, diabetes, pain, etc.) your subjects have.] Like Forms
A/B, Form C also has 18 items, but, instead o f a single 6 item powerful others subscale. Form C has two,
independent 3 item subscales: doctor, and other people.
We consider all three forms o f the MHLC to be "in public domain." That means that you are free
to use the scales in vour research (and to alter them for your research in any way you choose) without
obtaining our explicit permission. We do ask, however, that you cite the scales correctly ifrwhen you use
them*. If you profit monetarily from the use o f our scales, we expect that a suitable contribution would be
made to "The Vanderbilt Health Care Research Project." If you are a student, vou have our permission to
include a copy o f our scalefsl in the appendix to vour thesis or dissertation: otherwise, it would be
unethical to publish these scales without obtaining our explicit written permission to do so.
I have recently written and copyrighted a manual for the use of the MHLC scales. It is not
necessary for you to purchase a copy of this manual in order to use the scales, but, if you would like
to purchase a copy, please send a check for $10.00 (US) made out to "Vanderbilt University" to: Health
Care Research Project; School o f Nursing; Vanderbilt University Medical Center; Nashville, TN 37240.
5/95
*If you need/want to cite Form C , you may use the following citation:
Wallston, K A ., Stein, M .J., & Sm ith, C A . (1993). Forni C o f the MHLC Scales: A condition-specific health locus o f
control scale. J o u r n a l o f P erso n ality Assessment. 63. 534-553.
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Appendix F

Date: 7-12-96
To: Lori Booms
From: Arm P. Johnson, EdD, RN, CS

You have my permission to use my tool ‘Measurement of Compliance with a Comprehensive
COPD Treatment Program’ for development and completion of your master’s thesis in nursing. I
would appreciate a copy of the results you obtain. Best of luck to you in your academic
endeavors. If I can be of further assistance, please let me know.

Dr. Ann P. Johnson
Associate Dean
College of Applied Sciences
203 Belk Building
Western Carolina University
Cullowhee, NC 28723
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Appendix G

GRAND VALLEY STATE UNIVERSITY
KIRXBOF SCHOOL OF NURSING
STANDARD RELEASE FORM

I,
\^ Q o > a .\o t
______________________ , h ereb y g iv e p e r m is s io n
t o th e Grand V a lle y S t a t e U n iv e r s it y , K irk h of S ch o o l o f N ursing,
1.

To utilize photographs, films, video or audio taped segments of

s e l f f o r e d u c a tio n a l p u r p o se s.

v/

2.

To cop y o r reproduce th e f o llo w in g m a t e r ia l( s ) fo r e d u c a t io n a l
p u rp o ses by f a c u lt y a n d /o r s t u d e n t s w it h in s a id i n s t i t u t i o n :

V ^ e.A \ V-W \ j Q . \ o e
Çpr-

p o r fto ta g ,

•~T~V\e*ô‘S . (- o r

D ate:

10-21-96

V 'S c
Ç-

q

r-g_O rocj>

L_or>

o c ->^

RO

__________
Q~

M

__________________

S ig n a tu r e
Name P r in te d :

D onald E. K orlsk y

I n s t itu t io n /A g e n c y :
A ddress :
C ity :
S ta te :

U n iv e r s it y o f C a lif o r n ia , Los A n g ele s

Donald E. Morisky, Sc.D., M.S.P.H.
UCLA, School of Public Health
26-070 CHS
10833 Le Conte Ave.
Los Angeles. CA 90095 - 1772

___________
___________
-----------------

W itn ess :
D ate:

9 5 /9 6

/W/77/Y7/ S W i/d -

19

P ^ / s h Z n f . JJP

T h e s i s Handbook
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Appendix H

9 -1 1 -9 6

I, Cathy Schepers, RRT, give Lori Booms RN, MSN student GVSU, permission to use
class rosters from the Pulmonary Education Program to be used as a mailing list for
potential participants in a research study looking at Locus o f Control, Health Value, and
Adherence to a therapeutic regimen in patients with Chronic Obstructive Pulmonary
Disease. I understand that I am entitled to request a copy o f the results o f the study
when complete, and minimal risks are associated with completion o f the questionnaires.
All information will be kept confidential and in no way impact the care delivered to the
patients.

/n

r

c. S C H E I ^ RRT
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Appendix I

GRAND
VAJLLEY
STATE
UNIVERSITY
1 CAMPUS DRIVE. ALLENDALE MICHIGAN 49401-9403.616/895-6611

January?, 1997

Lori Booms
100 E. M orrestow n Rd.
Lake City, M I 49651

D ear Lori:

Preceived Control o f Chronic Obstructive
Pulmonary Disease and Adherence to a Therapeutic Regimen has been reviewed.
Y our proposed project entitled

It has been approved as a study w hich is exem pt from the regulations by section
46.101 o f the Federal Register 46(16):8336, January26, 1981.

Sincerely,

Paul Huizenga, C hair
H um an R esearch R eview Commiffee
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Appendix J

Appendix J

Dear Breathing My Best Class Member,
My name is Lori Booms and I am a graduate nursing student at Grand
Valley State University. I am doing a study that asks people with lung
disease about their feelings about their disease. Please enjoy the cup of
coffee I have sent while doing this study. I want to know your ideas about
your medicine, exercise, and your diet.
Filling out the survey should take about 30 minutes. It is your choice to
do the survey and by filling out the survey you agree to be part of this study.
All your answers are confidential and will only be seen by me. The only risk
to you is becoming tired. Please return the survey in the envelope included.
If you have any questions you can call me at 1-616-229-4820 or
Grand Valley State University Human Subjects Review Chairman, Dr. Paul
Huizenga, 1-616-895-2472.
Thank You,
Lori Booms RN BSN
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